Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Gross Profit (2016 - 2025)

Historic Gross Profit for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $157.4 million.

  • Prestige Consumer Healthcare's Gross Profit fell 228.5% to $157.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $619.3 million, marking a year-over-year increase of 48.99%. This contributed to the annual value of $634.5 million for FY2025, which is 160.38% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Gross Profit stood at $157.4 million for Q4 2025, which was down 228.5% from $151.6 million recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Gross Profit registered a high of $170.0 million during Q1 2025, and its lowest value of $137.1 million during Q1 2021.
  • For the 5-year period, Prestige Consumer Healthcare's Gross Profit averaged around $154.6 million, with its median value being $156.2 million (2021).
  • Its Gross Profit has fluctuated over the past 5 years, first soared by 1878.27% in 2021, then plummeted by 559.31% in 2024.
  • Prestige Consumer Healthcare's Gross Profit (Quarter) stood at $155.1 million in 2021, then decreased by 3.0% to $150.4 million in 2022, then grew by 5.01% to $157.9 million in 2023, then increased by 1.97% to $161.0 million in 2024, then decreased by 2.29% to $157.4 million in 2025.
  • Its Gross Profit stands at $157.4 million for Q4 2025, versus $151.6 million for Q3 2025 and $140.3 million for Q2 2025.